About DEVA
DEVA is a publicly listed company based in Istanbul (Turkey) founded in 1958. Generic pharmaceuticals and APIs are manufactured on contract. It operates on a Direct-to-Consumer (D2C) and Reseller / Distribution model. Its website deva.com.tr draws about 72 thousand monthly visits. DEVA offers products and services including Antineoplastics and Immunomodulators, Dermatology Products, and Boğaziçi Kolonyaları. Its focus areas include Pharmaceuticals and Drug Manufacturing. Its legal entity is DEVA Holding.
Company details
DEVA Holding, established in 1958, is engaged in the production of pharmaceuticals in Turkey. The company operates across multiple sectors including oncology and dermatology. Production is facilitated through three facilities and a logistics center located in Kartepe and Çerkezköy. Emphasis is placed on research and development to pioneer generic drug development. International expansion is pursued to establish a global presence in the pharmaceutical industry.
- Headquarters Istanbul, Turkey
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website deva.com.tr/tr
- Social LinkedIn Facebook Instagram
- Legal Name Deva Holding A.S.
- Annual Revenue$448.04 M (USD)24.5as on Dec 31, 2025
- Net Profit-$18.78 M (USD)-1262.48as on Dec 31, 2025
- EBITDA$32.58 M (USD)-44.78as on Dec 31, 2025
Products & Services of DEVA
DEVA offers a comprehensive portfolio of products and services, including Antineoplastics and Immunomodulators, Dermatology Products, and Boğaziçi Kolonyaları.
Drugs for cancer treatment and immune system modulation.
Medications for skin conditions and related treatments.
Cologne products offered for personal care use.
IPO & Listings of DEVA
DEVA is a publicly listed company on the BIST with ticker symbol DEVA in Turkey, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date21 Mar 1986
- Listed onIST: DEVA
- Listed entityDeva Holding A.S.
- Exchange sectorHealth technology
- ISINTRADEVAW91E2
- Share price78.80 TRY (-2.66% on the day) · 2026-10-14
- Market capitalisation16,189,224,926.00 TRY
- Price to earnings35.8
- EPS (diluted, trailing year)-4.21 TRY
- Volume (last session)202,927
Financials of DEVA
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 19.25B TRY | -807.0M TRY | 1.40B TRY |
| 2024 | 15.46B TRY | 69.4M TRY | 2.53B TRY |
| 2023 | 11.33B TRY | 3.39B TRY | 1.71B TRY |
| 2022 | 4.48B TRY | 1.36B TRY | 1.34B TRY |
| 2021 | 2.33B TRY | 1.17B TRY | 896.1M TRY |
Detailed financial statements for DEVA
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of DEVA
The website of DEVA (deva.com.tr) receives about 72.3K visits a month and ranks #469,247 among all websites worldwide, #448 in Biotechnology and Pharmaceuticals.
- Monthly visits72.3K
▲ 12% vs previous month
- Unique visitors37.2K
per month
- Global rank#469,247
among all websites
- Category rank#448
Health · Biotechnology and Pharmaceuticals
- Bounce rate45%
- Pages per visit3.0
- Average visit1 min 11 sec
- DevicesDesktop 37% · Mobile 63%
Websites whose visitors overlap most with DEVA. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
farma-tek.com | farma-tek.com | 100% | #3,152,871 | – | |
abdiibrahim.com.tr | abdiibrahim.com.tr | 90% | #180,526 | – | |
ilacabak.com | ilacabak.com | 88% | #25,146 | – | |
| santafarma.com.tr | 87% | #332,566 | View details | ||
| demilac.com.tr | 80% | 1.9K | #6,310,367 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 37 similar websites and full traffic analytics for DEVA
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 37 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Deva
Complete news archive for DEVA
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DEVA
DEVA was founded in 1958.
DEVA is headquartered in Istanbul, Turkey.
Annual revenue of DEVA is $448.04M as on Dec 31, 2025.
DEVA Holding, established in 1958, is engaged in the production of pharmaceuticals in Turkey. The company operates across multiple sectors including oncology and dermatology. Production is facilitated through three facilities and a logistics center located in Kartepe and Çerkezköy. Emphasis is placed on research and development to pioneer generic drug development. International expansion is pursued to establish a global presence in the pharmaceutical industry.
DEVA offers Antineoplastics and Immunomodulators, Dermatology Products, and Boğaziçi Kolonyaları.
Yes, DEVA is publicly traded on BIST under the ticker symbol DEVA.
DEVA operates through Deva Holding.